Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas - Zhou, Xieda; Wu, Liting; Chen, Yan; Xiao, Huangmeng; Huang, Xiaoyu; Li, Yanbing; Xiao, Haipeng; Cao, Xiaopei (Journal of diabetes investigation, 2021)
Keywords: Aged; Amputation; Arteriosclerosis; Atherosclerosis; Atherosclerosis - drug therapy; Atherosclerosis - etiology; Atherosclerosis - pathology; Atorvastatin; Atorvastatin - administration & dosage; Blood pressure; Body mass index; Cardiovascular disease; Cholesterol; Cholesterol, LDL - blood; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - pathology; Drug Administration Schedule; Female; Femur; Femur - pathology; Glucose; Glucose metabolism; High‐density lipoprotein cholesterol; Hormone replacement therapy; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage; Lipid metabolism; Lipids; Lipids - blood; Lipoproteins; Low density lipoprotein; Lower Extremity - pathology; Lower extremity atherosclerotic disease; Male; Metabolism; Middle Aged; Mortality; Original; Patients; Plaque, Atherosclerotic - drug therapy; Plaque, Atherosclerotic - etiology; Plaque, Atherosclerotic - pathology; Quinolines - administration & dosage; Smoking; Software; Standard deviation; Statins; Treatment Outcome; Ultrasonic imaging; Uric acid; China; High-density lipoprotein cholesterol; Lower extremity atherosclerotic disease; Statins